Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other financing activities: 2016-2020

Historic Other financing activities for Organogenesis Holdings (ORGO) over the last 5 years, with Dec 2020 value amounting to $5.7 million.

  • Organogenesis Holdings' Other financing activities rose 564.75% to $924,000 in Q3 2019 from the same period last year, while for Sep 2019 it was $2.7 million, marking a year-over-year increase of 223.23%. This contributed to the annual value of $5.7 million for FY2020, which is 90.25% up from last year.
  • Per Organogenesis Holdings' latest filing, its Other financing activities stood at $5.7 million for FY2020, which was up 90.25% from $3.0 million recorded in FY2019.
  • In the past 5 years, Organogenesis Holdings' Other financing activities ranged from a high of $5.7 million in FY2020 and a low of $270,000 during FY2018.
  • Its 3-year average for Other financing activities is $3.0 million, with a median of $3.0 million in 2019.
  • Per our database at Business Quant, Organogenesis Holdings' Other financing activities plummeted by 73.00% in 2018 and then soared by 1,001.11% in 2019.
  • Organogenesis Holdings' Other financing activities (Yearly) stood at $348,761 in 2016, then surged by 186.73% to $1.0 million in 2017, then plummeted by 73.00% to $270,000 in 2018, then skyrocketed by 1,001.11% to $3.0 million in 2019, then spiked by 90.25% to $5.7 million in 2020.